Aktis Oncology Inc Receivables Turnover Ratio (AKTS), from the second quarter 2026 to the second quarter 2024 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Aktis Oncology Inc   (NASDAQ: AKTS)
    Sector  Technology    Industry Consumer Electronics
   Industry Consumer Electronics
   Sector  Technology
 

Aktis Oncology Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2024

Quarterly Results, Trends, Rankings, Statistics


Aktis Oncology Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 10.08, above the company average. This is a clear sign of healthy business climate in the Consumer Electronics industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Aktis Oncology Inc in Jun 30 2026 quarter, has decreased to 36 days, compared to 46 days, in the Mar 31 2026 quarter.

If we take a look into Technology sector 567 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 3173 to 3304.

What is Receivable Turnover Ratio?
What is Aktis Oncology Inc Selling?


What is Receivable Turnover Ratio?





AKTS Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Sep 30 2024)
I. Quarter
Y / Y Receivable Change - - - -2.79 % -17.72 %
Y / Y Revenue Change -62.51 % -44.88 % -78.68 % -79.38 % 28.92 %
Receivable Turnover Ratio (TTM) 10.08 7.9 5.88 5.61 6.88
AKTS's Total Ranking # 3304 # 3173 # # #
Accounts Receivable average collection period days 36 46 62 65 53
Seq. Receivable Change - - - -2.02 % -12.07 %
Seq. Revenue Change 4.87 % 101.56 % 10.64 % -83.97 % 54.18 %


Receivable Turnover Company Ranking
Within: No.
Consumer Electronics Industry # 42
Technology Sector # 568
Overall Market # 3304

Receivable Turnover Ratio Statistics
High Average Low
0.34 0.11 0.03
(Sep 30 2024)   (Mar 31 2019)






Financial Statements
Aktis Oncology Inc 's Accounts Receivable $ 0 Millions Visit AKTS's Balance sheet
Aktis Oncology Inc 's Sales TTM $ 10 Millions Visit AKTS's Income Statement
Sources of AKTS's Revenues Visit AKTS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Consumer Electronics Industry Accounts Receivable Turnover Trends and Statistics
Technology Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AKTS's Receivable Turnover Ratio versus Consumer Electronics Industry, Technology Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AKTS's Growth Rates AKTS's Roa AKTS's Inventory Turnover Ratio AKTS's Dividend Comparisons
AKTS's Profitability Ratios AKTS's Roi AKTS's Asset Turnover Ratio AKTS's Dividend Growth
AKTS's Valuation Ratios AKTS's Roe AKTS's Financial Strength Ratios AKTS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Technology Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026

Date modified: 2026-09-03T11:29:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.